| Name | Zolbetuximab |
|---|
| Description | Zolbetuximab (IMAB362) is a monoclonal antibody targeting Claudin-18.2. Zolbetuximab mediates specific killing of Claudin-18.2-positive cells through immune effector mechanisms. Zolbetuximab can be used for the research of gastrointestinal adenocarcinomas and pancreatic tumors[1]. |
|---|---|
| Related Catalog | |
| References |
| No Any Chemical & Physical Properties |